UPANOVIMAB
UNII 8E88WSA6X3

Substance Identification & Data

This profile provides standardized clinical and technical data for Upanovimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8E88WSA6X3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2500633-46-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8E88WSA6X3

CAS Registry Number

2500633-46-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

UPANOVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175228

National Cancer Institute reference terminology for clinical and research data.

INN ID

11966

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Upanovimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

UPANOVIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL SCTA01 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCTA01 .KAPPA.-CHAIN, DIMER

SCTA 01 [WHO-DD]

UPANOVIMAB [INN]